<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: drugs  prescriptions</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'drugs  prescriptions'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22drugs++prescriptions%22&t=%22drugs++prescriptions%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:58:00 +0100</lastBuildDate>
        <item>
            <title>Sorrell vs. IMS Health: Not a Privacy Case</title>
            <link>http://www.medworm.com/index.php?rid=4968464&amp;cid=t_434408_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FkY82WaVaaUo%2F</link>
            <description>By Jim HarperThe Supreme Court&amp;#8217;s decision in Sorrell vs. IMS Health is being touted in many quarters as a privacy case, and a concerning one at that. Example: Senator Patrick Leahy (D-VT) released a statement saying &amp;#8220;the Supreme Court has overturned a sensible Vermont law that sought to protect the privacy of the doctor-patient relationship.&amp;#8221; That&amp;#8217;s a stretch.
The Vermont law at issue restricted the sale, disclosure, and use of pharmacy records that revealed the prescribing practices of doctors if that information was to be used in marketing by pharmaceutical manufacturers. Under the law, prescription drug salespeople&amp;#8212;&amp;#8221;detailers&amp;#8221; in industry parlance&amp;#8212;could not access information about doctors&amp;#8217; prescribing to use in focusing their effort...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4968464</comments>
            <pubDate>Fri, 24 Jun 2011 12:37:08 +0100</pubDate>
            <guid isPermaLink="false">4968464</guid>        </item>
        <item>
            <title>The proposals to implement ‘generic substitution’ in primary care, further to the Pharmaceutical Price Regulation Scheme (PPRS) 2009. Consultation document</title>
            <link>http://www.medworm.com/index.php?rid=3148997&amp;cid=t_434408_86_f&amp;fid=36669&amp;url=http%3A%2F%2Ffadelibrary.wordpress.com%2F2010%2F01%2F06%2Fthe-proposals-to-implement-generic-substitution-in-primary-care-further-to-the-pharmaceutical-price-regulation-scheme-pprs-2009-consultation-document%2F</link>
            <description>Title: The proposals to implement &amp;#8216;generic substitution&amp;#8217; in primary care, further to the Pharmaceutical Price Regulation Scheme (PPRS) 2009. Consultation document
Skinny: Consultation on generic substitution which will enable pharmacists and other dispensers to fulfil a prescription for a branded medicine by dispensing an equivalent generic medicine. Provision will be made to allow the prescriber to opt out of substitution
where, in his clinical judgment, it is appropriate for the patient to receive a specific branded medicine. 3 options are presented for consultation:

Do nothing
Introduce dispensing flexibility but with specific exclusions, so that the arrangements do not apply to a selected group of products on an exempt list.
Introduce dispensing flexibility but limiting th...</description>
            <author>Fade Library</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3148997</comments>
            <pubDate>Wed, 06 Jan 2010 19:22:06 +0100</pubDate>
            <guid isPermaLink="false">3148997</guid>        </item>
        <item>
            <title>Ever Disobeyed Your Doctor’s Orders?</title>
            <link>http://www.medworm.com/index.php?rid=2974182&amp;cid=t_434408_136_f&amp;fid=39025&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Feverythingchangesbook%2F%7E3%2FEd4jXvDH8-U%2Fcancer-patient-compliance</link>
            <description>When it comes to following prescription drug dosing and directions, I’m like a teacher’s pet.  I’m terrified of potential drug side effects – almost to a neurotic and paranoid level.  And I do exactly what my doctor says.  But many patients don’t or can’t.  Especially with the economy in the crapper, I know a lot of people who are splitting pills or skipping out of medications all together.
There have been times, however, when I’ve made educated decisions to go against my doctors’ orders for procedures.  I don’t have a medical degree, but I do have a ton of common sense and research the hell out of my disease.   And sometimes it makes more sense to me to disobey what my doctor is recommending. Here’s an example:
The last time my doc ordered a biopsy of nodes that...</description>
            <author>Everything Changes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2974182</comments>
            <pubDate>Mon, 09 Nov 2009 08:45:27 +0100</pubDate>
            <guid isPermaLink="false">2974182</guid>        </item>
        <item>
            <title>Drug Firms Woo Democrats, Helping Defeat Their Bills -</title>
            <link>http://www.medworm.com/index.php?rid=1300271&amp;cid=t_434408_122_f&amp;fid=35056&amp;url=http%3A%2F%2Frenegadeneurologist.com%2Fdrug-firms-woo-democrats-helping-defeat-their-bills%2F</link>
            <description>Fromwashingtonpost.com
The pharmaceutical industry, long an ally of Republicans, has increasingly worked itself into the good graces of the Democratic Party and by doing so has helped block the Democrats&amp;#8217; top prescription-drug initiatives.
Drug firms also have engaged former top aides to Congress&amp;#8217;s most important Democratic lawmakers, ensuring access to each of the leaders. These lobbyists once worked for such lawmakers as House Speaker Nancy Pelosi (Calif.); Senate Finance Committee Chairman Max Baucus (Mont.); House Ways and Means Committee Chairman Charles B. Rangel (N.Y.); and Edward M. Kennedy (Mass.), chairman of the Senate Committee on Health, Education, Labor and Pensions.
PhRMA&amp;#8217;s member companies, which include Merck, Eli Lilly and Pfizer, and their employees hav...</description>
            <author>Renegade Neurologist - A Blog by David Perlmutter, MD, FACN</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1300271</comments>
            <pubDate>Thu, 13 Mar 2008 18:42:32 +0100</pubDate>
            <guid isPermaLink="false">1300271</guid>        </item>
        <item>
            <title>Chemically-Induced Suicide: 80 Percent of Suicide Victims Took Antidepressant Drugs</title>
            <link>http://www.medworm.com/index.php?rid=1294318&amp;cid=t_434408_122_f&amp;fid=35056&amp;url=http%3A%2F%2Frenegadeneurologist.com%2Fchemically-induced-suicide-80-percent-of-suicide-victims-took-antidepressant-drugs%2F</link>
            <description>FromNaturalNews.com 
A Swedish writer has accused the National Board of Health and Welfare (NBHW) of covering up evidence suggesting a connection between psychiatric drugs and suicide. Under a recent law, Swedish health-care providers must fill out reports on all suicides committed by patients under their care or within four weeks of a health care visit. The reports are then sent to the NBHW, which compiles and analyzes them.
Recently, the NBHW released the first report analyzing the 367 suicides recorded in 2006. &amp;#8220;Not a single word is written about the most compelling fact: Well over 80 percent of persons killing themselves were treated with psychiatric drugs,&amp;#8221; Janne Larson writes.
According to data received via a Freedom of Information Act request, more than 80 percent of the...</description>
            <author>Renegade Neurologist - A Blog by David Perlmutter, MD, FACN</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1294318</comments>
            <pubDate>Tue, 11 Mar 2008 14:39:16 +0100</pubDate>
            <guid isPermaLink="false">1294318</guid>        </item>
        <item>
            <title>Class Action Brought Against Makers of Parkinson’s Drugs</title>
            <link>http://www.medworm.com/index.php?rid=1283398&amp;cid=t_434408_122_f&amp;fid=35056&amp;url=http%3A%2F%2Frenegadeneurologist.com%2Fclass-action-brought-against-makers-of-parkinson%25e2%2580%2599s-drugs%2F</link>
            <description>From NaturalNews.com 
A class action by a law firm in Melbourne (Australia) is about to be taken against two pharmaceutical companies that produce drugs for treating Parkinson&amp;#8217;s disease. The action is being taken due to side effects caused by the drugs and the lack of warnings given to doctors and their patients about these side effects.
Parkinson&amp;#8217;s disease results from an imbalance of dopamine which regulates movement. Parkinson&amp;#8217;s can effect people differently but typical symptoms include trembling or shaking, muscle stiffness and slow body movements.
The Parkinson&amp;#8217;s drugs at issue are of a class of drugs known as dopamine agonists. These agonists restore the imbalance of dopamine in the brain. And while they also stimulate the reward centre in the brain, they can ...</description>
            <author>Renegade Neurologist - A Blog by David Perlmutter, MD, FACN</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1283398</comments>
            <pubDate>Thu, 06 Mar 2008 12:51:09 +0100</pubDate>
            <guid isPermaLink="false">1283398</guid>        </item>
        <item>
            <title>Antibiotics Do Little for Inner Ear Infections</title>
            <link>http://www.medworm.com/index.php?rid=1261591&amp;cid=t_434408_122_f&amp;fid=35056&amp;url=http%3A%2F%2Frenegadeneurologist.com%2Fantibiotics-do-little-for-inner-ear-infections%2F</link>
            <description>No reason to give them to kids to try to prevent fluid buildup, analysis shows
From HealthDay
Antibiotics don&amp;#8217;t significantly reduce fluid buildup in young children with inner ear infections, a new analysis shows.
Whether such drugs work in this regard has been a matter of conjecture, with one recent study suggesting a benefit in children aged 2 and under. So, Dutch researchers did a meta-analysis of several previously published studies and found the results don&amp;#8217;t support the use of antibiotics for the fluid buildup that can accompany inner ear infections.
&amp;#8220;Due to the marginal effect and the known negative effects of prescribing antibiotics, such as the development of antibiotic resistance and side effects, we do not recommend prescribing antibiotics to prevent middle ear...</description>
            <author>Renegade Neurologist - A Blog by David Perlmutter, MD, FACN</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1261591</comments>
            <pubDate>Wed, 27 Feb 2008 16:06:01 +0100</pubDate>
            <guid isPermaLink="false">1261591</guid>        </item>
        <item>
            <title>Researchers Find a Bias Toward Upbeat Findings on Antidepressants</title>
            <link>http://www.medworm.com/index.php?rid=1173087&amp;cid=t_434408_122_f&amp;fid=35056&amp;url=http%3A%2F%2Frenegadeneurologist.com%2Fresearchers-find-a-bias-toward-upbeat-findings-on-antidepressants%2F</link>
            <description>From New York Times
The makers of antidepressants like Prozac and Paxil never published the results of about a third of the drug trials that they conducted to win government approval, misleading doctors and consumers about the drugs true effectiveness, a new analysis has found.
In published trials, about 60 percent of people taking the drugs report significant relief from depression, compared with roughly 40 percent of those on placebo pills. But when the less positive, unpublished trials are included, the advantage shrinks: the drugs outperform placebos, but by a modest margin, concludes the new report, which appears Thursday in The New England Journal of Medicine.
Previous research had found a similar bias toward reporting positive results for a variety of medications; and many researche...</description>
            <author>Renegade Neurologist - A Blog by David Perlmutter, MD, FACN</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1173087</comments>
            <pubDate>Wed, 23 Jan 2008 22:29:00 +0100</pubDate>
            <guid isPermaLink="false">1173087</guid>        </item>
        <item>
            <title>Drug ads may not give balanced information</title>
            <link>http://www.medworm.com/index.php?rid=1133812&amp;cid=t_434408_122_f&amp;fid=35056&amp;url=http%3A%2F%2Frenegadeneurologist.com%2Fdrug-ads-may-not-give-balanced-information%2F</link>
            <description>From United Press International 
U.S. researchers found that most prescription drug ads do not present a fair balance of information, especially about side effect risks.
Researchers led by Wendy Macias of the University of Georgia analyzed a week&amp;#8217;s worth of direct-to-consumer ads on broadcast and cable television and found that the average 60-second ad contained less than 8 seconds of side effect disclaimers, while the average 30-second ad had less than 4.4 seconds of disclaimers. Most of the 15-second ads studied devoted no time at all to disclaimers.
&amp;#8220;These ads clearly don&amp;#8217;t devote enough time to information about risk,&amp;#8221; Macias said in a statement. &amp;#8220;Adding to the problem is that the information is often presented in a way that people aren&amp;#8217;t likely to c...</description>
            <author>Renegade Neurologist - A Blog by David Perlmutter, MD, FACN</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1133812</comments>
            <pubDate>Mon, 07 Jan 2008 22:36:59 +0100</pubDate>
            <guid isPermaLink="false">1133812</guid>        </item>
        <item>
            <title>Why I am using Actos (pioglitazone) in ALS treatment</title>
            <link>http://www.medworm.com/index.php?rid=1084166&amp;cid=t_434408_122_f&amp;fid=35056&amp;url=http%3A%2F%2Frenegadeneurologist.com%2Fwhy-i-am-using-actos-pioglitazone-in-als-treatment%2F</link>
            <description>Here is link : The Oral Antidiabetic Pioglitazone Protects from Neurodegeneration and Amyotrophic Lateral Sclerosis-Like Symptoms in Superox&amp;#8230;
Amyotrophic lateral sclerosis (ALS) represents a fatal neurodegenerative disorder characterized by progressive death of the upper and lower motor neurons. Because accompanying inflammation may interact with and promote neurodegeneration, anti-inflammatory treatment strategies are being evaluated. Because peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists act as potent anti-inflammatory drugs, we tested whether superoxide dismutase (SOD1)-G93A transgenic mice, a mouse model of ALS, benefit from oral treatment with the PPAR gamma agonist pioglitazone (Pio). Pio-treated transgenic mice revealed improved muscle strength and b...</description>
            <author>Renegade Neurologist - A Blog by David Perlmutter, MD, FACN</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1084166</comments>
            <pubDate>Mon, 10 Dec 2007 17:20:36 +0100</pubDate>
            <guid isPermaLink="false">1084166</guid>        </item>
    </channel>
</rss>

